Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC + CBD and Memory Study
NCT04855526Phase 1Not yet recruiting
- Sponsor
- Hartford Hospital
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of cannabis (3 arms), sponsored by Hartford Hospital. Primary endpoints: fMRI response at 1 hour and Glutamate levels at 1 hour. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
cannabis
Beyond the preview
Go deeper on NCT04855526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04855526.